Finance

Beta
Lists
RUBICON:NSE
Rubicon Research Ltd
₹1,227.00
-5.48%
(-71.20) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
₹1,300.00
High
₹1,329.50
Low
₹1,118.10
Mkt. cap
199.04B
Avg. vol.
614.69K
Volume
637.69K
P/E ratio
80.14
52-wk high
₹1,370.00
52-wk low
₹570.75
EPS
₹15.31
No. of employees
1K
Open
₹1,300.00
High
₹1,329.50
Low
₹1,118.10
Mkt. cap
199.04B
Avg. vol.
614.69K
Volume
637.69K
P/E ratio
80.14
52-wk high
₹1,370.00
52-wk low
₹570.75
EPS
₹15.31
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to RUBICON in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for RUBICON in the last 3 months.
Highest
Current ₹1,227.00
₹1,160.00 (-5.46%)
Average
₹1,160.00 (-5.46%)
Lowest
₹1,160.00 (-5.46%)
News stories
From sources across the web
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1.14K
Founded1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.52B
4.12B
4.76B
5.17B
Cost of goods sold
1.06B
1.27B
1.57B
1.69B
Cost of revenue
1.06B
1.27B
1.57B
1.69B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
584.80M
633.59M
663.73M
683.53M
Operating expense
1.81B
2.03B
2.22B
2.38B
Total operating expenses
2.87B
3.30B
3.79B
4.07B
Operating income
658.68M
824.26M
965.73M
1.09B
Other non operating income
-19.44M
6.97M
37.87M
-
EBT including unusual items
595.56M
717.05M
905.86M
986.87M
EBT excluding unusual items
595.56M
717.05M
905.86M
986.87M
Income tax expense
162.55M
178.53M
177.89M
219.02M
Effective tax rate
27.29%
24.90%
19.64%
22.19%
Other operating expenses
1.12B
1.28B
1.44B
1.58B
Net income
433.01M
538.52M
727.97M
767.85M
Net profit margin
12.28%
13.07%
15.31%
14.87%
Earnings per share
-
3.47
4.41
4.60
Interest and investment income
3.24M
-
-
-
Interest expense
-85.10M
-114.18M
-97.74M
-103.60M
Net interest expenses
-81.86M
-114.18M
-97.74M
-103.60M
Depreciation and amortization charges
95.72M
118.71M
115.53M
122.66M
EBITDA
720.55M
976.82M
1.12B
1.20B
Gain or loss from assets sale
-
7.63M
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more